IDH2 somatic mutations in chronic myeloid leukemia patients in blast crisis (Q58023817)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20962862%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

title

IDH2 somatic mutations in chronic myeloid leukemia patients in blast crisis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20962862%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

1 reference

1 reference

chronic myeloid leukemia

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20962862%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

Annalisa Lonetti

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20962862%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

Anna Ferrari

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20962862%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

Andreas Hochhaus

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20962862%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

Alberto Ferrarini

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20962862%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

Nicholas Cross

18

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20962862%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

author name string

J Score

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20962862%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

I Iacobucci

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20962862%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

A Poerio

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20962862%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

A Gnani

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20962862%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

S Colarossi

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20962862%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

F Castagnetti

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20962862%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

G Rosti

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20962862%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

F Cervantes

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20962862%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

M Delledonne

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20962862%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

M Sazzini

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20962862%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

D Luiselli

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20962862%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

M Baccarani

17

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20962862%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

G Martinelli

19

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20962862%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

publication date

21 October 2010

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20962862%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20962862%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

volume

25

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20962862%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20962862%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

page(s)

178-181

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20962862%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/leu.2010.236

15 February 2020

exact match

0 references

cites work

Molecular alterations of the IDH1 gene in AML: a Children's Oncology Group and Southwest Oncology Group study

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.236

The JAK2 46/1 haplotype confers susceptibility to essential thrombocythemia regardless of JAK2V617F mutational status-clinical correlates in a study of 226 consecutive patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.236

Mutations of IDH1 and IDH2 genes in early and accelerated phases of myelodysplastic syndromes and MDS/myeloproliferative neoplasms

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.236

IDH1 and IDH2 mutation studies in 1473 patients with chronic-, fibrotic- or blast-phase essential thrombocythemia, polycythemia vera or myelofibrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.236

Recurrent IDH mutations in high-risk myelodysplastic syndrome or acute myeloid leukemia with isolated del(5q).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.236

WHO-defined 'myelodysplastic syndrome with isolated del(5q)' in 88 consecutive patients: survival data, leukemic transformation rates and prevalence of JAK2, MPL and IDH mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.236

Nilotinib for the frontline treatment of Ph(+) chronic myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.236

An integrated genomic analysis of human glioblastoma multiforme

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.236

Analysis of the IDH1 codon 132 mutation in brain tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.236

IDH1 mutations at residue p.R132 (IDH1(R132)) occur frequently in high-grade gliomas but not in other solid tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.236

Type and frequency of IDH1 and IDH2 mutations are related to astrocytic and oligodendroglial differentiation and age: a study of 1,010 diffuse gliomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.236

Mutational analysis of IDH1 codon 132 in glioblastomas and other common cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.236

Isocitrate dehydrogenase 1 codon 132 mutation is an important prognostic biomarker in gliomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.236

IDH1 mutations are early events in the development of astrocytomas and oligodendrogliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.236

IDH1 and IDH2 mutations in gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.236

Cancer-associated IDH1 mutations produce 2-hydroxyglutarate

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.236

The common feature of leukemia-associated IDH1 and IDH2 mutations is a neomorphic enzyme activity converting alpha-ketoglutarate to 2-hydroxyglutarate

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.236

Contribution of reactive oxygen species to 3-hydroxyglutarate neurotoxicity in primary neuronal cultures from chick embryo telencephalons

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.236

D-2-hydroxyglutaric acid induces oxidative stress in cerebral cortex of young rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.236

Metabolism and the leukemic stem cell.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.236

Recurring mutations found by sequencing an acute myeloid leukemia genome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.236

IDH1 and IDH2 gene mutations identify novel molecular subsets within de novo cytogenetically normal acute myeloid leukemia: a Cancer and Leukemia Group B study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.236

Impact of IDH1 R132 mutations and an IDH1 single nucleotide polymorphism in cytogenetically normal acute myeloid leukemia: SNP rs11554137 is an adverse prognostic factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.236

Distinct clinical and biologic characteristics in adult acute myeloid leukemia bearing the isocitrate dehydrogenase 1 mutation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.236

Acquired mutations in the genes encoding IDH1 and IDH2 both are recurrent aberrations in acute myeloid leukemia: prevalence and prognostic value

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.236

Prognostic impact of isocitrate dehydrogenase enzyme isoforms 1 and 2 mutations in acute myeloid leukemia: a study by the Acute Leukemia French Association group

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.236

IDH1 and IDH2 mutations are frequent genetic alterations in acute myeloid leukemia and confer adverse prognosis in cytogenetically normal acute myeloid leukemia with NPM1 mutation without FLT3 internal tandem duplication

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.236

Prognostic impact of IDH2 mutations in cytogenetically normal acute myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.236

Taxing sugar-sweetened beverages

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.236

Genetic analysis of transforming events that convert chronic myeloproliferative neoplasms to leukemias

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.236

IDH1 mutations in patients with myelodysplastic syndromes are associated with an unfavorable prognosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.236

Identification and molecular characterization of recurrent genomic deletions on 7p12 in the IKZF1 gene in a large cohort of BCR-ABL1-positive acute lymphoblastic leukemia patients: on behalf of Gruppo Italiano Malattie Ematologiche dell'Adulto Acute

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.236

IDH1 and IDH2 mutation analysis in chronic- and blast-phase myeloproliferative neoplasms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.236

inferred from DOI database lookup

7 January 2021

based on heuristic

Somatic mutations of IDH1 and IDH2 in the leukemic transformation of myeloproliferative neoplasms

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.236

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/LEU.2010.236

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20962862%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

1 reference